Published in Medical Letter on the CDC and FDA, October 9th, 2005
T-cell activation plays an important role in the immunopathogenesis of RA. The company presented preclinical and clinical data, and discussed the proposed pharmacovigilance program. The FDA is not bound by the committee's recommendations.
Bristol-Myers Squibb completed its submission of a biologics license application (BLA) to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.